Literature DB >> 28642311

Run-in bias in randomised trials: the case of COPD medications.

Samy Suissa1.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28642311     DOI: 10.1183/13993003.00361-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

1.  New Treatment Options for COPD: How Do We Decide Phenotypes, Endotypes or Treatable Traits?

Authors:  Ron Balkissoon
Journal:  Chronic Obstr Pulm Dis       Date:  2018-01-18

2.  Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD.

Authors:  Nicola A Hanania; Alberto Papi; Antonio Anzueto; Fernando J Martinez; Kimberly A Rossman; Christy S Cappelletti; Elizabeth A Duncan; Jack S Nyberg; Paul M Dorinsky
Journal:  ERJ Open Res       Date:  2020-04-27

3.  Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety.

Authors:  Samy Suissa; Sophie Dell'Aniello; Pierre Ernst
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-08-30

4.  Microenterprise Intervention to Reduce Sexual Risk Behaviors and Increase Employment and HIV Preventive Practices Among Economically-Vulnerable African-American Young Adults (EMERGE): A Feasibility Randomized Clinical Trial.

Authors:  Larissa Jennings Mayo-Wilson; Jessica Coleman; Fatmata Timbo; Fred M Ssewamala; Sebastian Linnemayr; Grace T Yi; Bee-Ah Kang; Matthew W Johnson; Gayane Yenokyan; Brian Dodge; Nancy E Glass
Journal:  AIDS Behav       Date:  2020-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.